Organon Operating Income from 2010 to 2026
| OGN Stock | USD 8.21 0.11 1.36% |
Operating Income | First Reported 2020-03-31 | Previous Quarter 326 M | Current Value 358 M | Quarterly Volatility 154.7 M |
Check Organon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organon's main balance sheet or income statement drivers, such as Depreciation And Amortization of 236.8 M, Interest Expense of 627.9 M or Selling General Administrative of 1.2 B, as well as many indicators such as Price To Sales Ratio of 1.05, Dividend Yield of 0.0434 or PTB Ratio of 9.81. Organon financial statements analysis is a perfect complement when working with Organon Valuation or Volatility modules.
Organon | Operating Income | Build AI portfolio with Organon Stock |
Evaluating Organon's Operating Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Organon Co's fundamental strength.
Latest Organon's Operating Income Growth Pattern
Below is the plot of the Operating Income of Organon Co over the last few years. Operating Income is the amount of profit realized from Organon operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Organon Co is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Organon's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organon's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Organon Operating Income Regression Statistics
| Arithmetic Mean | 2,662,170,588 | |
| Geometric Mean | 2,514,110,810 | |
| Coefficient Of Variation | 31.67 | |
| Mean Deviation | 740,249,827 | |
| Median | 3,272,000,000 | |
| Standard Deviation | 843,191,923 | |
| Sample Variance | 710972.6T | |
| Range | 2.5B | |
| R-Value | (0.81) | |
| Mean Square Error | 255257.8T | |
| R-Squared | 0.66 | |
| Significance | 0.000069 | |
| Slope | (136,002,941) | |
| Total Sum of Squares | 11375561.9T |
Organon Operating Income History
About Organon Financial Statements
Organon investors utilize fundamental indicators, such as Operating Income, to predict how Organon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | 1.3 B | 1.9 B |
Pair Trading with Organon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.Moving together with Organon Stock
Moving against Organon Stock
| 0.82 | HPQ | HP Inc | PairCorr |
| 0.59 | MSFT | Microsoft | PairCorr |
| 0.43 | BRK-A | Berkshire Hathaway | PairCorr |
| 0.32 | IBM | International Business | PairCorr |
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Organon Correlation against competitors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Pharmaceuticals sector continue expanding? Could Organon diversify its offerings? Factors like these will boost the valuation of Organon. Anticipated expansion of Organon directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.56) | Dividend Share 0.6 | Earnings Share 1.98 | Revenue Per Share | Quarterly Revenue Growth 0.013 |
Investors evaluate Organon using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organon's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organon's market price to deviate significantly from intrinsic value.
It's important to distinguish between Organon's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organon should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organon's market price signifies the transaction level at which participants voluntarily complete trades.